R. Shivakumar, “Pyrimidine-Piperazine Hybrids as Potential PARP1 Inhibitors: Dual in silico and in vitro Approaches against Breast Cancer”, ajc, vol. 38, no. 4, pp. 956–962, Apr. 2026.